Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...
Beta Bionics has announced the pricing of its upsized initial public offering of 12 million shares of common stock at a price to the public of $17 per share.
The lawyer behind a series of high-profile legal challenges to DEI practices is suing Bally’s and the city of Chicago over a $250 million IPO the suit says is unlawfully open only to people of color ...
A RECENTLY passed bill that will cut the tax on stock transactions to 0.1% from 0.6% is expected to make the Philippine stock market more appealing to investors, according to economists, who also ...